Pulmonx Raises $32 Million for Launch of Emphysema Products
?We are pleased to have these two top-tier global investors join us as we embark on the commercial launch of our Chartis System and Zephyr valve for the treatment of emphysema?
Dr. Rodney Perkins, Founder and Chairman of Pulmonx commented, ?This funding will allow the Pulmonx team under Mike?s experienced leadership to better support our physicians and extend this innovative therapy to the millions of patients with this devastating disease.?
http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20100222007130&newsLang=en
?We are pleased to have these two top-tier global investors join us as we embark on the commercial launch of our Chartis System and Zephyr valve for the treatment of emphysema?
Dr. Rodney Perkins, Founder and Chairman of Pulmonx commented, ?This funding will allow the Pulmonx team under Mike?s experienced leadership to better support our physicians and extend this innovative therapy to the millions of patients with this devastating disease.?
http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20100222007130&newsLang=en